(MENAFN- EIN Presswire)
Facial Injectable Market
Technological advancements and the rising use of social media have resulted in growing awareness and acceptance of facial injectables among men.
Facial injectables are being used in a wide range of applications, including facial line correction, lip augmentation, facelift, acne scar treatment, and lipoatrophy treatment.” - Polaris
market ResearchNEW YORK CITY, NY, UNITED STATES, October 7, 2024 /EINPresswire / -- Our market report on facial injectables has been prepared using advanced methodologies and research techniques to help businesses make strategic business decisions.
The market for facial injectables is on a growth trajectory. Our latest analysis reveals that the facial injectable market size was valued at USD 11.60 billion in 2023 and is projected to grow to USD 33.63 billion by 2032. It is projected to exhibit a CAGR of 12.6% from 2024 to 2032.
Market Introduction:
Facial injectables, also known as dermal fillers, are substances injected into the skin to enhance facial features and reduce aging signs. They are used to make up for the decreased amount of collagen in the skin, which leads to skin laxity and loss of volume. Getting dermal fillers can add volume to sagging skin and help smoothen wrinkles and creases on the face. Also, these fillers are used to plump up lips and cheeks and make the facial features more symmetrical.
There are several types of dermal fillers, including hyaluronic acid, calcium hydroxyapatite, poly-l-lactic acid, and polymethylmethacrylate. Hyaluronic acid, a naturally occurring acid in the skin, adds volume to the skin and keeps it hydrated. Calcium hydroxyapatite and poly-l-lactic acid are used for deeper wrinkles, whereas polymethylmethacrylate gives skin volume and keeps it firm. With rising disposable income and growing affordability of cosmetics procedures, the facial injectable market demand is projected to rise.
Download Free Sample PDF Copy of the Report:
/request-for-sample
Key Report Highlights:
.The market for facial injectables is projected to reach USD 33.63 billion by 2032, exhibiting a CAGR of 12.6% from 2024 to 2032.
.Facial injectables are being widely used to enhance facial aesthetics by reducing wrinkles, adding volume, and rejuvenating skin.
.The facial injectable market segmentation is primarily based on product, application, end-use, and region.
.The key regions covered in the research report are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Top Market Participants:
.Allergan Aesthetics (AbbVie)
.BIOPLUS CO., LTD.
.Bioxis Pharmaceuticals
.GALDERMA
.Ipsen Pharma
.Merz Pharma
.Medytox
.Prollenium Medical Technologies
.SINCLAIR PLASTIC SURGERY
.Teoxane.
are some of the facial injectable market key players.
These players are making significant investments in research & development initiatives to improve their product offerings. Also, they are adopting several strategic initiatives to expand their global presence.
Some of the latest market developments are:
.In August 2023, Maypharm CO, Ltd announced the launch of METOOFILL, a hyaluronic acid dermal filler with advanced second-generation technology. The introduction of the new dermal filler sets new standards in cosmetic innovation.
.In October 2022, Prollenium Group acquired SoftFil to improve its product portfolio with advanced medical devices and dermal fillers. The new acquisition emphasizes Prollenium's focus on innovation in aesthetic medicine.
Market Drivers and Opportunities:
Drivers:
Minimally Invasive Cosmetic Procedures: The growing demand for cosmetic procedures and minimally invasive or noninvasive surgeries is driving the facial injectable market growth. Consumers are increasingly opting for procedures like botulinum toxin and dermal fillers to get more youthful appearances.
Increasing FDA Approvals: The growing rate of FDA approvals is another factor propelling the market demand. FDA approvals improve consumer confidence in the efficacy and safety of new products, resulting in increased adoption of cosmetic products like facial injectables.
Opportunities:
Growing Acceptance: With the rising prevalence of social media and advances in technology, the awareness and acceptance of facial injectables among men has increased. This, in turn, is having a favorable impact on the facial injectable market share.
Request for a Discount on this Report Before Purchase:
/request-for-discount-pricing
Regional Overview:
North America: North America dominated the market for facial injectables in 2023. This is primarily due to the increasing number of procedures being performed in the region. More individuals in North America are opting for nonsurgical treatments and procedures to enhance facial features and address signs of aging.
Asia Pacific: Asia Pacific is anticipated to witness the fastest CAGR in the facial injectable market from 2024 to 2032. The region's demand is propelled by an expanding aging population opting for cosmetic enhancements. Besides, the growing disposable incomes and booming beauty industry further propel the regional market expansion.
Inquire more about this report before purchase:
/inquire-before-buying
Market Segmentation:
By Product Outlook:
.Collagen & PMMA Microspheres
.Botulinum Toxin Type A
.Hyaluronic Acid (HA)
.Calcium Hydroxylapatite (CaHA)
.Poly-L-lactic Acid (PLLA)
.Others
By Application Outlook:
.Facial Line Correction
.Lip Augmentation
.Face Lift
.Acne Scar Treatment
.Lipoatrophy Treatment
.Others
By End-Use Outlook:
.MedSpa
.Dermatology Clinics
.Hospitals
By Regional Outlook:
.North America
oUS
oCanada
.Europe
oGermany
oFrance
oUK
oItaly
oSpain
oNetherlands
oRussia
oRest of Europe
.Asia Pacific
oChina
oJapan
oIndia
oMalaysia
oSouth Korea
oIndonesia
oAustralia
oVietnam
oRest of Asia Pacific
.Middle East & Africa
oSaudi Arabia
oUAE
oIsrael
oSouth Africa
oRest of Middle East & Africa
.Latin America
oMexico
oBrazil
oArgentina
oRest of Latin America
Browse PMR's Facial Injectable Market Report Coverage from Different Publications:
Facial Injectable Market Size Set for 12.6% CAGR Growth, Projected to Hit USD 33.63 Billion by 2032 | Polaris Market Research:
Browse More Research Reports:
Brain Tumor Diagnosis and Therapeutics Market:
Flexible Paper Packaging Market:
X-Ray Photoelectron Spectroscopy Market:
Blood Plasma Market:
Audiology Devices Market:
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN07102024003118003196ID1108753103